Simple Cardiac Pharm: Is it Plumbing or Electrical?

Mastering Bedside Judgment for Cardiac Meds
I. Heart Failure (HF) Therapeutic Combinations
Managing Heart Failure requires a delicate balance of fluid volume and cardiac protection.

The "Triple Threat" Protocol: A standard combination of an ACE inhibitor (e.g., Lisinopril), a beta-blocker (e.g., Metoprolol), and a loop diuretic (e.g., Furosemide/Lasix) works synergistically to reduce fluid overload and protect the heart muscle.

Digoxin and Furosemide (Lasix): Furosemide flushes fluid but "wastes" potassium. Low potassium (hypokalemia) allows Digoxin to bind more heavily to heart cells, drastically increasing the risk of Digoxin toxicity.

Lisinopril and Spironolactone: While effective at preventing cardiac remodeling and fluid retention, both medications promote potassium retention. This combination requires strict monitoring for life-threatening hyperkalemia.

II. Post-Myocardial Infarction (MI) Regimens
Bedside judgment is critical when discharging a patient after a STEMI or stent placement.

Acute MI Discharge: Patients are typically prescribed sublingual Nitroglycerin, Metoprolol, and Lisinopril.

Nitroglycerin Safety: Instruct patients on the "Rule of Three": take one tablet for chest pain; if not relieved in 5 minutes, call 911 and take a second (up to three tablets total in 15 minutes). Pro-tip: Nurses must wear gloves when applying Nitro paste to avoid a severe, sudden headache and hypotension.

III. Atrial Fibrillation and Stroke Prevention
Anticoagulation: Warfarin (Coumadin) is often used to prevent clot formation in the atria.

Monitoring: Frequent PT/INR checks are mandatory. Patients must maintain consistent Vitamin K intake (leafy greens) and be warned that antibiotics can kill gut bacteria that produce Vitamin K, potentially making Warfarin dangerously potent.

IV. Deep Vein Thrombosis (DVT) Bridging
Heparin to Warfarin Bridge: Because Warfarin takes 3 to 5 days to become therapeutic, patients often receive continuous IV Heparin as a "bridge" to provide immediate protection against clot expansion.

V. Stent Placement and Acute Coronary Syndrome (ACS)
Dual Antiplatelet Therapy (DAPT): Usually a combination of Aspirin and Clopidogrel (Plavix) to prevent platelets from clumping on the new stent.

Critical Note: Aspirin’s effects last 7–10 days (the life of a platelet) and cannot be reversed, making GI bleeds or emergency surgeries high-risk events.

Go to SuperNurse.ai for more super fun nursing resources!

Need to reach out? Send an email to [e-mail]